3-methylcholanthrene has been researched along with curcumin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Krishna, TP; Krishnaswamy, K; Polasa, K; Sesikaran, B | 1 |
Donatus, IA; Vermeulen, NP | 1 |
Ashida, H; Nishiumi, S; Yoshida, K | 1 |
Anto, RJ; Bava, SV; Sreekanth, CN; Sreekumar, E | 1 |
4 other study(ies) available for 3-methylcholanthrene and curcumin
Article | Year |
---|---|
Turmeric (Curcuma longa)-induced reduction in urinary mutagens.
Topics: Administration, Oral; Animals; Benzo(a)pyrene; Body Weight; Curcumin; Dose-Response Relationship, Drug; Histiocytoma, Benign Fibrous; Male; Methylcholanthrene; Mutagenicity Tests; Mutagens; Rats; Rats, Inbred Strains | 1991 |
Cytotoxic and cytoprotective activities of curcumin. Effects on paracetamol-induced cytotoxicity, lipid peroxidation and glutathione depletion in rat hepatocytes.
Topics: Acetaminophen; Animals; Catechols; Cells, Cultured; Curcumin; Glutathione; L-Lactate Dehydrogenase; Lipid Peroxidation; Liver; Male; Methylcholanthrene; Rats; Rats, Inbred Strains | 1990 |
Curcumin suppresses the transformation of an aryl hydrocarbon receptor through its phosphorylation.
Topics: Active Transport, Cell Nucleus; Animals; Aryl Hydrocarbon Receptor Nuclear Translocator; Cell Line, Tumor; Cell Nucleus; Curcumin; Cytochrome P-450 CYP1A1; Environmental Pollutants; Enzyme Activation; In Vitro Techniques; Methylcholanthrene; Mice; Phosphorylation; Polychlorinated Dibenzodioxins; Protein Kinase C; Rats; Receptors, Aryl Hydrocarbon | 2007 |
Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspases; Cell Membrane; Cell Proliferation; Curcumin; Disease Models, Animal; DNA Fragmentation; Down-Regulation; Drug Synergism; Enzyme Activation; Female; HeLa Cells; Humans; Liposomes; MAP Kinase Signaling System; Methylcholanthrene; Mice; Mitogen-Activated Protein Kinases; NF-kappa B; Paclitaxel; Poly Adenosine Diphosphate Ribose; Proto-Oncogene Proteins c-akt; Transcription Factor AP-1; Transcription, Genetic; Tumor Burden; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2011 |